Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has received a consensus recommendation of “Buy” from the five analysts that are presently covering the firm, MarketBeat.com reports. Five analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have issued ratings on the stock in the last year […]
Clearside Biomedical (NASDAQ:CLSD – Get Free Report)‘s stock had its “market outperform” rating reissued by stock analysts at JMP Securities in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $5.00 price target on the stock. JMP Securities’ target price indicates a potential upside of 429.10% from the […]
Clearside Biomedical (NASDAQ:CLSD) Stock Rating Reaffirmed by Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Clearside Biomedical, Inc (NASDAQ:CLSD) Short Interest Down 22 4% in July themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Free Report) has earned a consensus rating of “Buy” from the four research firms that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokers that have updated their coverage on the stock […]